Literature DB >> 12960780

APOE and cerebral amyloid angiopathy in the elderly.

Seth Love1, James A R Nicoll, Anthony Hughes, Gordon K Wilcock.   

Abstract

Over 30% of normal elderly people have cerebral amyloid angiopathy (CAA). Possession of APOE epsilon4 is associated with increased prevalence and severity of CAA in Alzheimer's disease (AD) and in cerebral haemorrhage. We examined CAA in relation to APOE genotype in brains from 152 people aged 60-102 years, without AD or cerebral haemorrhage. Prevalence of CAA increased with age (p = 0.003). CAA was not associated with APOE genotype. The frequency of epsilon4 showed a significant negative association with age (p = 0.016). Age at death was significantly lower in those with than without epsilon4 (p = 0.028). Possession of epsilon4 does not by itself confer an increased risk of CAA but may be associated with reduced longevity even in the absence of AD or cerebral haemorrhage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960780     DOI: 10.1097/00001756-200308060-00027

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  17 in total

Review 1.  Apolipoprotein E in Alzheimer's disease and other neurological disorders.

Authors:  Philip B Verghese; Joseph M Castellano; David M Holtzman
Journal:  Lancet Neurol       Date:  2011-03       Impact factor: 44.182

2.  The max-intracerebral hemorrhage score predicts long-term outcome of intracerebral hemorrhage.

Authors:  Yue Suo; Wei-Qi Chen; Yue-Song Pan; Yu-Jing Peng; Hong-Yi Yan; Xing-Quan Zhao; Li-Ping Liu; Yi-Long Wang; Gai-Fen Liu; Yong-Jun Wang
Journal:  CNS Neurosci Ther       Date:  2018-03-12       Impact factor: 5.243

3.  The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice.

Authors:  Mafalda Cacciottolo; Amy Christensen; Alexandra Moser; Jiahui Liu; Christian J Pike; Conor Smith; Mary Jo LaDu; Patrick M Sullivan; Todd E Morgan; Egor Dolzhenko; Andreas Charidimou; Lars-Olof Wahlund; Maria Kristofferson Wiberg; Sara Shams; Gloria Chia-Yi Chiang; Caleb E Finch
Journal:  Neurobiol Aging       Date:  2015-10-19       Impact factor: 4.673

Review 4.  Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy.

Authors:  Vitaly Vasilevko; Giselle F Passos; Daniel Quiring; Elizabeth Head; Richard C Kim; Mark Fisher; David H Cribbs
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

Review 5.  The role of APOE in cerebrovascular dysfunction.

Authors:  Leon M Tai; Riya Thomas; Felecia M Marottoli; Kevin P Koster; Takahisa Kanekiyo; Alan W J Morris; Guojun Bu
Journal:  Acta Neuropathol       Date:  2016-02-16       Impact factor: 17.088

Review 6.  Cerebral Hypoperfusion and the Energy Deficit in Alzheimer's Disease.

Authors:  Seth Love; J Scott Miners
Journal:  Brain Pathol       Date:  2016-09       Impact factor: 6.508

7.  Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue.

Authors:  Seth Love; Katy Chalmers; Paul Ince; Margaret Esiri; Johannes Attems; Kurt Jellinger; Masahito Yamada; Mark McCarron; Thais Minett; Fiona Matthews; Steven Greenberg; David Mann; Patrick Gavin Kehoe
Journal:  Am J Neurodegener Dis       Date:  2014-03-28

Review 8.  Impact of age-related neuroglial cell responses on hippocampal deterioration.

Authors:  Joseph O Ojo; Payam Rezaie; Paul L Gabbott; Michael G Stewart
Journal:  Front Aging Neurosci       Date:  2015-04-29       Impact factor: 5.750

9.  Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia.

Authors:  Rachel Barker; Emma L Ashby; Dannielle Wellington; Vivienne M Barrow; Jennifer C Palmer; Patrick G Kehoe; Margaret M Esiri; Seth Love
Journal:  Brain       Date:  2014-03-10       Impact factor: 13.501

Review 10.  Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review.

Authors:  Hannah A D Keage; Roxanna O Carare; Robert P Friedland; Paul G Ince; Seth Love; James A Nicoll; Stephen B Wharton; Roy O Weller; Carol Brayne
Journal:  BMC Neurol       Date:  2009-01-13       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.